187 related articles for article (PubMed ID: 18852267)
21. Effects of mutation on the amyloidogenic propensity of apolipoprotein C-II(60-70) peptide.
Todorova N; Hung A; Maaser SM; Griffin MD; Karas J; Howlett GJ; Yarovsky I
Phys Chem Chem Phys; 2010 Nov; 12(44):14762-74. PubMed ID: 20938536
[TBL] [Abstract][Full Text] [Related]
22. Avoiding the oligomeric state: αB-crystallin inhibits fragmentation and induces dissociation of apolipoprotein C-II amyloid fibrils.
Binger KJ; Ecroyd H; Yang S; Carver JA; Howlett GJ; Griffin MD
FASEB J; 2013 Mar; 27(3):1214-22. PubMed ID: 23159935
[TBL] [Abstract][Full Text] [Related]
23. A structural model for apolipoprotein C-II amyloid fibrils: experimental characterization and molecular dynamics simulations.
Teoh CL; Pham CL; Todorova N; Hung A; Lincoln CN; Lees E; Lam YH; Binger KJ; Thomson NH; Radford SE; Smith TA; Müller SA; Engel A; Griffin MD; Yarovsky I; Gooley PR; Howlett GJ
J Mol Biol; 2011 Feb; 405(5):1246-66. PubMed ID: 21146539
[TBL] [Abstract][Full Text] [Related]
24. Solution Conditions Affect the Ability of the K30D Mutation To Prevent Amyloid Fibril Formation by Apolipoprotein C-II: Insights from Experiments and Theoretical Simulations.
Mao Y; Todorova N; Zlatic CO; Gooley PR; Griffin MD; Howlett GJ; Yarovsky I
Biochemistry; 2016 Jul; 55(27):3815-24. PubMed ID: 27311794
[TBL] [Abstract][Full Text] [Related]
25. Fluphenazine·HCl and Epigallocatechin Gallate Modulate the Rate of Formation and Structural Properties of Apolipoprotein C-II Amyloid Fibrils.
Zlatic CO; Mao Y; Ryan TM; Mok YF; Roberts BR; Howlett GJ; Griffin MD
Biochemistry; 2015 Jun; 54(24):3831-8. PubMed ID: 26021642
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein E.
Gunzburg MJ; Perugini MA; Howlett GJ
J Biol Chem; 2007 Dec; 282(49):35831-41. PubMed ID: 17916554
[TBL] [Abstract][Full Text] [Related]
27. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops.
Hatters DM; MacPhee CE; Lawrence LJ; Sawyer WH; Howlett GJ
Biochemistry; 2000 Jul; 39(28):8276-83. PubMed ID: 10889036
[TBL] [Abstract][Full Text] [Related]
28. A cyclic peptide inhibitor of apoC-II peptide fibril formation: mechanistic insight from NMR and molecular dynamics analysis.
Griffin MD; Yeung L; Hung A; Todorova N; Mok YF; Karas JA; Gooley PR; Yarovsky I; Howlett GJ
J Mol Biol; 2012 Mar; 416(5):642-55. PubMed ID: 22244853
[TBL] [Abstract][Full Text] [Related]
29. Methionine oxidation inhibits assembly and promotes disassembly of apolipoprotein C-II amyloid fibrils.
Binger KJ; Griffin MD; Howlett GJ
Biochemistry; 2008 Sep; 47(38):10208-17. PubMed ID: 18729385
[TBL] [Abstract][Full Text] [Related]
30. Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin.
Hatters DM; Wilson MR; Easterbrook-Smith SB; Howlett GJ
Eur J Biochem; 2002 Jun; 269(11):2789-94. PubMed ID: 12047389
[TBL] [Abstract][Full Text] [Related]
31. Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
Legge FS; Binger KJ; Griffin MD; Howlett GJ; Scanlon D; Treutlein H; Yarovsky I
J Phys Chem B; 2009 Oct; 113(42):14006-14. PubMed ID: 19780547
[TBL] [Abstract][Full Text] [Related]
32. "Janus" cyclic peptides: a new approach to amyloid fibril inhibition?
Todorova N; Yeung L; Hung A; Yarovsky I
PLoS One; 2013; 8(2):e57437. PubMed ID: 23437387
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of peptide aggregation by lipids: insights from coarse-grained molecular simulations.
Hung A; Yarovsky I
J Mol Graph Model; 2011 Feb; 29(5):597-607. PubMed ID: 21146432
[TBL] [Abstract][Full Text] [Related]
34. Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils.
Hill SE; Miti T; Richmond T; Muschol M
PLoS One; 2011 Apr; 6(4):e18171. PubMed ID: 21483680
[TBL] [Abstract][Full Text] [Related]
35. Cross-linking and amyloid formation by N- and C-terminal cysteine derivatives of human apolipoprotein C-II.
Pham CL; Hatters DM; Lawrence LJ; Howlett GJ
Biochemistry; 2002 Dec; 41(48):14313-22. PubMed ID: 12450397
[TBL] [Abstract][Full Text] [Related]
36. Effects of oxidation, pH and lipids on amyloidogenic peptide structure: implications for fibril formation?
Hung A; Griffin MD; Howlett GJ; Yarovsky I
Eur Biophys J; 2008 Nov; 38(1):99-110. PubMed ID: 18769912
[TBL] [Abstract][Full Text] [Related]
37. Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II.
Hatters DM; Minton AP; Howlett GJ
J Biol Chem; 2002 Mar; 277(10):7824-30. PubMed ID: 11751863
[TBL] [Abstract][Full Text] [Related]
38. The interaction of human apolipoprotein C-I with sub-micellar phospholipid.
Atcliffe BW; MacRaild CA; Gooley PR; Howlett GJ
Eur J Biochem; 2001 May; 268(10):2838-46. PubMed ID: 11358499
[TBL] [Abstract][Full Text] [Related]
39. Molecular dynamics simulations of a fibrillogenic peptide derived from apolipoprotein C-II.
Legge FS; Treutlein H; Howlett GJ; Yarovsky I
Biophys Chem; 2007 Nov; 130(3):102-13. PubMed ID: 17825978
[TBL] [Abstract][Full Text] [Related]
40. Lipid concentration effects on the amyloidogenic apoC-II(60-70) peptide: a computational study.
Todorova N; Hung A; Yarovsky I
J Phys Chem B; 2010 Jun; 114(23):7974-82. PubMed ID: 20496878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
